Your email has been successfully added to our mailing list.

×
0.063590909090909 0.0818181818181817 0.0862727272727273 0.0181818181818182 -0.0181818181818182 -0.0227272727272728 -0.0290454545454547 -0.0386363636363636
Stock impact report

US Patent Office Grants Key Risk Test Patent

Genetic Technologies Ltd - American Depositary Shares (GENE) 
US:NASDAQ Investor Relations: gtgcorporate.com/investor-centre
Company Research Source: GlobeNewswire
Issuance of US Patent No: US 10,683,549, Methods for assessing risk of developing breast cancer.Filed provisional patent for its COVID-19 Severity Risk Test, 2020901739 – Methods of assessing risk developing a severe response to Coronavirus infection  MELBOURNE, Australia, June 18, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”) is pleased to announce the issuance of US Patent No: US 10,683,549, Methods for assessing risk of developing breast cancer. Genetic Technologies is the first company to successfully commercialise a polygenic risk test for breast cancer in the world.  Growth in number of papers mentioning polygenic risk in the title or abstract is an indication of increasing interest in the field. The granted Show less Read more
Impact Snapshot
Event Time:
GENE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for GENE alerts
Opt-in for
GENE alerts

from News Quantified
Opt-in for
GENE alerts

from News Quantified